Kyverna Therapeutics, Inc. KYTX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Kyverna Therapeutics, Inc. (KYTX) reported deferred tax assets and other non-current assets of $5.01M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets increased by 37.6% year-over-year, from $3.64M to $5.01M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 20.9% compound annual growth rate (CAGR), from $3.36M to $4.9M.